VistaGen Therapeutics Inc... (VTGN)
NASDAQ: VTGN
· Real-Time Price · USD
3.03
0.07 (2.54%)
At close: Aug 15, 2025, 11:41 AM
VistaGen Therapeutics Revenue
VistaGen Therapeutics reported an annual revenue of $486K, reflecting a -54.32% growth. For the quarter ending June 30, 2025, VistaGen Therapeutics generated $244K in revenue.
Revenue (ttm)
486K
Revenue Growth
-54.32%
Price / Sales Ratio
157.98
Revenue / Employee
10.13K
Employees
48
Market Cap
92.96M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|